To study the oncogenic role of the p210(bcr-abl) fusion protein in chr
onic myelogenous leukemia cells, we generated a mouse cell line that w
as stably transfected with and overexpressed the human p210(bcr-abl) f
usion protein, We then looked for phosphorylation activation of the Ja
nus-activated kinase (JAK) family of tyrosine-specific protein kinases
by the p210(bcr-abl) fusion protein, We found that JAK1, which has be
en shown by others to be associated with the IFN-alpha and -gamma plas
ma membrane receptors, was phosphorylated to a much greater degree in
cells containing the p210(bcr-abl) fusion protein than was the case in
the original, untransfected cell line. In contrast, no phosphorylatio
n of the JAK2 kinase, which is associated with the IFN-gamma but not I
FN-alpha receptor, was observed either with or without p210(bcr-abl) p
rotein. A substrate of JAK1, STAT1 (signal transducers and activators
of transcription 1), was found to be phosphorylated in cells containin
g overexpressed p210(bcr-abl) fusion protein, These results indicate t
hat the presence of the p210(bcr-abl) protein kinase within a cell is
associated with phosphorylation of the JAK1 kinase and its substrate S
TAT1.